Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene ...

Retrieved on: 2025-10-07 15:39:05

Tags for this article:

Click the tags to see associated articles and topics

Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene .... View article details on hiswai:

Excerpt

Monoclonal Antibodies Growth – Targeted therapies for myasthenia gravis and related disorders gaining rapid uptake. Regional Access – The U.S. and ...

Article found on: www.wvnews.com

View Original Article